[1]
Pradelli, L. et al. 2017. A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context. Farmeconomia. Health economics and therapeutic pathways. 18, 1 (Dec. 2017). DOI:https://doi.org/10.7175/fe.v18i1.1312.